2025-05-15 - Analysis Report
Okay, here's an analysis of Nike Inc. (NKE) based on the data you provided.

## Nike Inc. (NKE) Stock Analysis

**Company Overview:** Nike Inc. is a global leader in athletic footwear, apparel, equipment, and accessories.

### 1. Performance vs. S&P 500 (VOO)

*   **Nike Cumulative Return:** 0.0
*   **S&P 500 (VOO) Cumulative Return:** 0.0
*   **Disparity:**
    *   **Max Disparity:** 0.0
    *   **Min Disparity:** 0.0
    *   **Current Disparity:** 0.0
    *   **Relative Disparity:** 0.0

*Analysis:*  Since both cumulative returns are zero, there is no disparity to analyze. The relative disparity is also 0, indicating no deviation from the benchmark over the period.  This suggests either a starting point synchronization or a lack of movement in the stock and benchmark.

### Alpha, Beta Analysis

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|--------|
| 2015-2017  | 0.0% | 0.0% | 0.0%  | 1.0  | 84.8   |
| 2016-2018  | 0.0% | 0.0% | 0.0%  | 1.0  | 101.6  |
| 2017-2019  | 0.0% | 0.0% | 0.0%  | 1.0  | 140.3  |
| 2018-2020  | 0.0% | 0.0% | 0.0%  | 1.0  | 197.8  |
| 2019-2021  | 0.0% | 0.0% | 0.0%  | 1.0  | 234.8  |
| 2020-2022  | 0.0% | 0.0% | 0.0%  | 1.0  | 166.7  |
| 2021-2023  | 0.0% | 0.0% | 0.0%  | 1.0  | 156.6  |
| 2022-2024  | 0.0% | 0.0% | 0.0%  | 1.0  | 111.0  |
| 2023-2025  | 0.0% | 0.0% | 0.0%  | 1.0  | 91.5   |

*Analysis:*

*   **CAGR and MDD:**  The CAGR (Compound Annual Growth Rate) and MDD (Maximum Drawdown) are all 0.0% across all periods. This is highly unusual and suggests either the data is incomplete or there was virtually no price movement during these periods.
*   **Alpha:** An Alpha of 0.0% indicates that the stock has not outperformed or underperformed its benchmark (likely the S&P 500) on a risk-adjusted basis during these periods.
*   **Beta:** A Beta of 1.0 suggests that the stock's price moves in line with the market. It has the same volatility as the market.
*   **Cap(B):** This shows the market capitalization in billions. We see a general trend of increasing market cap from 2015-2021, followed by a decline.

### 2. Recent Stock Price Movement

*   **Current Price:** 62.04
*   **Last Market Data:** {'price': 61.9846, 'previousClose': 62.39, 'change': -0.65}
*   **5-Day Moving Average:** 60.09
*   **20-Day Moving Average:** 57.6125
*   **60-Day Moving Average:** 65.7445

*Analysis:*

*   The current price (62.04) is slightly above the last market price (61.9846), indicating a minor discrepancy that could be due to after-hours trading or data timing.
*   The price decreased from the previous close (-0.65), indicating a slight downward pressure in the last trading session.
*   The stock price is currently above both its 5-day and 20-day moving averages, but below its 60-day moving average.  This suggests that while there has been a recent upward trend (above 5 and 20 day MA), it's still below the longer-term trend (60 day MA).
*   The fact that the 5-day moving average is above the 20-day moving average also confirms the short-term upward momentum.

### 3. Market Risk Indicator and Other Indices

*   **Market Risk Indicator (MRI):** 0.0
*   **RSI:** 65.84867382600356
*   **PPO:** 1.729
*   **Recent (20-day) Relative Disparity Change:** 0.0 (-)
*   **Expected Return (%):** 0.0

*Analysis:*

*   **MRI:** A value of 0.0 suggests very low market risk according to this indicator. This may contradict other volatility signals. Check data integrity.
*   **RSI:** An RSI of 65.85 indicates that the stock is approaching overbought territory (typically above 70).  A correction or consolidation might be expected soon.
*   **PPO:** A PPO (Percentage Price Oscillator) of 1.729 indicates that the shorter-term moving average is above the longer-term moving average, confirming the recent upward trend.  The higher the PPO, the stronger the trend.
*   **Recent (20-day) Relative Disparity Change:** A value of 0.0 (-) indicates a short-term downward trend in relative performance compared to the benchmark.
*   **Expected Return:** An expected return of 0.0% suggests no anticipated outperformance compared to the S&P 500 over the long term, based on this model.

### 4. Recent News & Significant Events

*   **2025-05-11:** News highlights major business developments, regulatory changes, or market events.
*   **2025-05-15:** Analysts discussing Nike's performance in the context of industry trends and global economic factors.
*   **2025-05-12:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-05-14:** Experts highlight risks and opportunities, advising investors to monitor news and announcements.

*Analysis:* The news suggests potential volatility and significant developments impacting Nike. It is crucial to delve deeper into these news items to understand the specific drivers behind the stock's behavior. Keep an eye on any risks and opportunities mentioned.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2025-04-03 | 0.54 | 11.27 B$      |
| 2025-01-03 | 0.78 | 12.35 B$      |
| 2024-10-07 | 0.7  | 11.59 B$      |
| 2024-04-04 | 0.77 | 12.43 B$      |
| 2025-04-03 | 0.77 | 12.43 B$      |

*Analysis:*

*   The EPS (Earnings Per Share) figures show variability. Most recently 2025-04-03 EPS decreased to 0.54, which is a cause for concern.
*   Revenue also fluctuates but is generally in the 11-12 billion dollar range.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-02-28   | $11.27B   | 41.49%       |
| 2024-11-30   | $12.35B   | 43.62%       |
| 2024-08-31   | $11.59B   | 45.36%       |
| 2024-05-31   | $12.61B   | 44.69%       |
| 2024-02-29   | $12.43B   | 44.75%       |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-02-28   | $14.01B   | 5.67%   |
| 2024-11-30   | $14.04B   | 8.29%   |
| 2024-08-31   | $13.94B   | 7.54%   |
| 2024-05-31   | $14.43B   | 10.40%  |
| 2024-02-29   | $14.23B   | 8.24%   |

*Analysis:*

*   **Revenue and Profitability:** Revenue has fluctuated with a recent dip in the latest quarter (2025-02-28). The profit margin has also decreased in the last quarter, suggesting potential cost pressures or pricing adjustments.
*   **Capital and Profitability:** Equity has been relatively stable. ROE (Return on Equity) has decreased significantly in the latest quarter, which could be a concern for investors as it reflects reduced profitability relative to shareholder equity.

### 7. Overall Summary

Based on the provided data, here's a summary of Nike Inc. (NKE):

*   **Performance:** Cumulative returns are currently aligned with the S&P 500 (VOO), showing no outperformance or underperformance. However, the historical alpha data also shows this trend over various periods, but the recent RSI, PPO indicates uptrend, but the expected return is 0.0%.
*   **Stock Movement:** Recent price action shows a slight upward trend with the price above short-term moving averages.
*   **Market Risk:** The MRI suggests very low market risk, which may be inconsistent with the news indicating potential volatility.
*   **Earnings:** The latest earnings data show a decrease in both EPS and revenue, which could be a cause for concern.
*   **Financial Health:** While equity is stable, the latest quarterly data reveals a decline in both profit margin and ROE, suggesting weakening profitability.
*   **News:** Recent news indicates potential volatility and significant developments, suggesting the need for careful monitoring of the company.
*   **Recommendations:** The recent dip in revenue, profit margin, and ROE, combined with the potential volatility mentioned in the news, suggests a cautious approach. Further investigation into the reasons behind these trends is recommended.

**Important Considerations:**

*   **Data Integrity:** Several metrics (CAGR, MDD, Alpha across all periods, MRI) are unusual and may indicate data errors.  It's crucial to verify the accuracy of the input data.
*   **Forward-Looking Analysis:** This analysis is based solely on the provided data. A comprehensive investment decision should involve more in-depth research, including financial modeling, industry analysis, and consideration of macroeconomic factors.

I hope this is helpful! Let me know if you have any other questions.
